Aside from melanoma lesions, we also assessed the thyroid gland, whose dysfunction is a frequent endocrine irAE induced by PD-1 inhibitors [52,53], as well as primary and secondary lymphoid organs, given the critical impact of systemic immune responses for effective cancer immunotherapy [54]. Here, PDCD1 is linked to melanoma.